Literature DB >> 7438023

Olfactory esthesioneuroblastoma--variables predictive of tumor control and recurrence.

M J Homzie, D Elkon.   

Abstract

This report surveys the world literature concerning prognostic variables for patients with esthesioneuroblastoma, an uncommon tumor arising from the olfactory epithelium. Specific sites of local and regional tumor extension, recurrence of disease after treatment, distant metastasis, and patient age were all found to be related to patient prognosis. There is a higher cure rate for patients treated after 1966, indicating an improvement in treatment methods. Also, the results indicate that in more recent years patients are being diagnosed and treated with less advanced disease. A statistical procedure, discriminant analysis, was employed, which permits the oncologist to predict patient outcome accurately. The discriminant function equation was 87% correct in identifying patients with tumor control (for a minimum period of 36 months) or recurrence and was 84% correct in classifying patients free of disease for at least 60 months or with recurrence. The statistical procedures employed in this report can be extended to other tumors and survival criteria.

Entities:  

Mesh:

Year:  1980        PMID: 7438023     DOI: 10.1002/1097-0142(19801201)46:11<2509::aid-cncr2820461132>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Esthesioneuroblastoma: cerebral and spinal metastases without direct cranial invasion.

Authors:  D Ranjan; R G Hennessy
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

2.  Treatment of esthesioneuroblastoma with chemotherapy: a report of two cases.

Authors:  D O Heros; F H Hochberg
Journal:  J Neurooncol       Date:  1988-09       Impact factor: 4.130

3.  Esthesioneuroblastoma a case report.

Authors:  Snya Chadha; Kulwant Kaur Pannu
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-12

4.  Computed tomographic features of esthesioneuroblastoma.

Authors:  R W Hurst; S Erickson; W S Cail; S A Newman; P A Levine; J Burke; R W Cantrell
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

Review 5.  Chemotherapy for cranial base tumors.

Authors:  H E Jacob
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Pigmented esthesioneuroblastoma showing dual differentiation following transplantation in nude mice. An immunohistochemical, electron microscopical, and cytogenetic analysis.

Authors:  A Llombart-Bosch; C Carda; A Peydro-Olaya; R Noguera; J Boix; A Pellin
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival.

Authors:  Jamie J Van Gompel; Caterina Giannini; Kerry D Olsen; Eric Moore; Manolo Piccirilli; Robert L Foote; Jan C Buckner; Michael J Link
Journal:  J Neurol Surg B Skull Base       Date:  2012-10

8.  Maxillofacial esthesioneuroblastoma: A diagnostic complexity.

Authors:  G Shyam Raj; Guttikonda Venkateswara Rao; Manchikatla Praveen Kumar; Kondamari Sudheerkanth
Journal:  J Oral Maxillofac Pathol       Date:  2016 May-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.